Sage Plans New Trials And Approval Timeline For Zuranolone

Company Will Explore A Higher Dose For The Antidepressant

 
• By Jessica Merrill
  
Curving path during sunset cutting through a panoramic view of rolling green hilss
Sage sees a longer, but straightforward path for zuranolone • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category